{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:05:53Z","timestamp":1778785553344,"version":"3.51.4"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ITT"],"DOI":"10.2147\/itt.s31467","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T23:32:13Z","timestamp":1374535933000},"page":"61","source":"Crossref","is-referenced-by-count":8,"title":["Allergen immunotherapy: routes, safety,efficacy, and mode of action"],"prefix":"10.2147","author":[{"given":"Punita","family":"Ponda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hochfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7]]},"container-title":["ImmunoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=16831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:28:25Z","timestamp":1477852105000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/nbspallergen-immunotherapy-routes-safetyefficacy-and-mode-of-action-peer-reviewed-article-ITT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/itt.s31467","relation":{},"ISSN":["2253-1556"],"issn-type":[{"value":"2253-1556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}